(Total Views: 410)
Posted On: 03/05/2021 4:32:51 PM
Post# of 151717
CDiddy wrote:
Its interesting to me that they reduced the trial size (longhaulers) to 50 patients. To be honest, I dont understand why they would do this.
My response:
Maybe the FDA having seen our m/m trial results and having seen our s/c results, and knowing we will soon have an EUA for s/c. maybe they are in a hurry to get leronlimab to market for longhaulers also, and p value will not be as important as data.
Read More: https://investorshangout.com/post/view?id=607...z6oH8tlYAj
Its interesting to me that they reduced the trial size (longhaulers) to 50 patients. To be honest, I dont understand why they would do this.
My response:
Maybe the FDA having seen our m/m trial results and having seen our s/c results, and knowing we will soon have an EUA for s/c. maybe they are in a hurry to get leronlimab to market for longhaulers also, and p value will not be as important as data.
Read More: https://investorshangout.com/post/view?id=607...z6oH8tlYAj
(0)
(0)Scroll down for more posts ▼
